Evidence map›Paper›PMID 37380796›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2024

Robustness analysis of surface-guided DIBH left breast radiotherapy: personalized dosimetric effect of real intrafractional motion within the beam gating thresholds.

A Gnerucci, M Esposito, A Ghirelli, S Pini, L Paoletti, R Barca, S Fondelli, P Alpi, B Grilli, F Rossi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Development of a model to guide the decision for radiotherapy in deep-inspiration breath-hold in patients with left-sided breast cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

A GnerucciDepartment of Physics and Astronomy, University of Florence, Florence, Italy. alessio.gnerucci@unifi.it.ORCID 0000-0003-3799-8161
M EspositoMedical Physics Unit, Azienda USL Toscana Centro, Florence, Italy.
A GhirelliMedical Physics Unit, Azienda USL Toscana Centro, Florence, Italy.
S PiniMedical Physics Unit, Azienda USL Toscana Centro, Florence, Italy.
L PaolettiRadiotherapy Unit, Azienda USL Toscana Centro, Florence, Italy.
R BarcaRadiotherapy Unit, Azienda USL Toscana Centro, Florence, Italy.
S FondelliRadiotherapy Unit, Azienda USL Toscana Centro, Florence, Italy.
P AlpiRadiotherapy Unit, Azienda USL Toscana Centro, Florence, Italy.
B GrilliRadiotherapy Unit, Azienda USL Toscana Centro, Florence, Italy.
F RossiRadiotherapy Unit, Azienda USL Toscana Sud Est, Grosseto, Italy.
S ScocciantiRadiotherapy Unit, Azienda USL Toscana Centro, Florence, Italy.
S RussoMedical Physics Unit, Azienda USL Toscana Centro, Florence, Italy.
Azienda Usl Toscana Centro · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe robustness of surface-guided (SG) deep-inspiration breath-hold (DIBH) radiotherapy (RT) for left breast cancer was evaluated by investigating any potential dosimetric effects due to the residual intrafractional motion allowed by the selected beam gating thresholds. The potential reduction of DIBH benefits in terms of organs at risk (OARs) sparing and target coverage was evaluated for conformational (3DCRT) and intensity-modulated radiation therapy (IMRT) techniques.

methodsA total of 192 fractions of SGRT DIBH left breast 3DCRT treatment for 12 patients were analyzed. For each fraction, the average of the real-time displacement between the isocenter on the daily reference surface and on the live surface ("SGRT shift") during beam-on was evaluated and applied to the original plan isocenter. The dose distribution for the treatment beams with the new isocenter point was then calculated and the total plan dose distribution was obtained by summing the estimated perturbed dose for each fraction. Then, for each patient, the original plan and the perturbed one were compared by means of Wilcoxon test for target coverage and OAR dose-volume histogram (DVH) metrics. A global plan quality score was calculated to assess the overall plan robustness against intrafractional motion of both 3DCRT and IMRT techniques.

resultsTarget coverage and OAR DVH metrics did not show significant variations between the original and the perturbed plan for the IMRT techniques. 3DCRT plans showed significant variations for the left descending coronary artery (LAD) and the humerus only. However, none of the dose metrics exceeded the mandatory dose constraints for any of the analyzed plans. The global plan quality analysis indicated that both 3DCRT and IMRT techniques were affected by the isocenter shifts in the same way and, generally, the residual isocenter shifts more likely tend to worsen the plan in all cases.

conclusionThe DIBH technique proved to be robust against residual intrafractional isocenter shifts allowed by the selected SGRT beam-hold thresholds. Small-volume OARs located near high dose gradients showed significant marginal deteriorations in the perturbed plans with the 3DCRT technique only. Global plan quality was mainly influenced by patient anatomy and treatment beam geometry rather than the technique adopted.

Indexed as

Breast NeoplasmsRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedUnilateral Breast NeoplasmsBreath HoldingFemaleHumansOrgans at RiskRadiotherapy DosageRadiotherapy Planning, Computer-AssistedAuto-planningDose goalsIsocenter shiftOptical systemsVisual coaching

Identifiers

PMID37380796
OpenAlexW4382362014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.